New hope for treating neglected flesh-eating disease
Isabella Farrance reports the use of fosravuconazole for treating Mycetoma, and the social factors that may hinder its deployment.
clinical trials
Continue reading
PROTACs: Targeting breakdown of specific proteins to treat diseases
Felicites Rapon explores the advantages of PROTACs over small molecule inhibitors in addressing cancer treatment and drug resistance.
Metformin: The age-old elixir of life?
Ayush Sinha examines metformin’s role in longevity and reports on the highly-anticipated TAME trial set to further investigate its potential.
The science of skinny: Ozempic reinforces the obsession with thinness
Isabelle Goodall-Summers explores the off-label use of Ozempic for weight loss, highlighting potential societal implications.
The legacy of a girl who inspired a “holy grail” cancer-killing pill
Niamh Walker reports on the recent development of AOH1996, a pill targeting cancerous cells, offering a new approach to cancer treatment.
Checkpoints: Progress in cancer immunotherapy
Cecilia Jay describes the challenges facing immunotherapy as cancer treatment, and its potential to revolutionise personalised medicine .
A Potential Breakthrough in HIV Vaccine Development
Andrew Griffiths reports on results from a small-scale clinical trial showing a potential breakthrough in HIV vaccine development.
Transfusion of lab-grown red blood cells in pioneering clinical trial could revolutionise treatment of rare blood disorders
Caius Gibeily reports on the promising results from a phase I trial which transfused lab-grown red blood cells into healthy patients.
Have we finally found an effective vaccine against malaria?
Andrew Griffiths reports on the recently published findings from a malaria vaccine trial—do we now have an effective vaccine against malaria?
Do antidepressants actually work?
Joshua Mitchell reviews the debate over the role of serotonin in depression, and the evidence on whether antidepressants do actually work.
- 1
- 2